Determinant of time to default from treatment during treatment period of congestive heart failure patients in case of Felege Hiwot Referral Hospital, Bahir Dar, Ethiopia
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
Background: Like all other organs the Heart is susceptible to disease. The main objective of this study was to identify the factors that affect time-to default from treatment of congestive heart failure patients at Felege- Hiwot Referral Hospital, Bahir Dar, Ethiopia.
Method: A retrospective study design was conducted on congestive heart failure patients selected by inclusion and exclusion criteria at FHRH under a follow-up period from January 1st 2016 to December 31th 2019. Cox-Proportional hazard model for survival part time to default were used to identify factors that affect the time to default from the hospital.
Results: On the New York Heart Association Classification (NYHAC), 5.2% of the patients were class I and 14.9%, 36.1%, and 43.7% were found in classes II, III, and IV respectively. Patients with co morbidities like anaemia, pneumonia, chronic kidney disease were less likely to default as compared to patients without co morbidities. Patients’ New York Heart Association Class, Marital Status, Hypertension status of patients and TB co-infected status of CHF patients were found to be significant determinants of time to default.
Conclusion: the variable NYHAC, TB co-infected status and LVEF were common factors for time to default of CHF patients. The risk of defaulting for TB co-infected patients were higher as compared to non-TB co-infected patients with HR=8.24. Hence in hospital health professionals should be needed give special attention to the patients who had the co-morbidity disease. And government should allocate appropriate budget to hospital for hospitalization of CHF patients for the long time until recovery.
##plugins.themes.bootstrap3.displayStats.downloads##
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This open-access article is distributed under a Creative Commons Attribution (CC-BY) 4.0 license.
You are free to: Share — copy and redistribute the material in any medium or format. Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
How to Cite
References
Aalen, O., et al. (2008). Survival and event history analysis: a process point of view, Springer Science & Business Media.
Aarts, L. A., et al. (2013). "Non-contact heart rate monitoring utilizing camera photoplethysmography in the neonatal intensive care unit—A pilot study." Early human development 89(12): 943-948.
Agbor, V. N., et al. (2018). "Heart failure in sub-Saharan Africa: a contemporaneous systematic review and meta-analysis." International journal of cardiology 257: 207-215.
Ahmad, T., et al. (2017). "Survival analysis of heart failure patients: A case study." PloS one 12(7): e0181001
Benjamin, E. J., et al. (2018). "Heart disease and stroke statistics-2018 update: a report from the American Heart Association." Circulation 137(12): e67.
Bewick, V., et al. (2004). "Statistics review 12: survival analysis." Critical care 8(5): 389.
Boini, S., et al. (2004). "Impact of cancer occurrence on health-related quality of life: A longitudinal pre-post assessment." Health and quality of life outcomes 2(1): 4.
ChuDuc, H., et al. (2013). "A review of heart rate variability and its applications." APCBEE procedia 7: 80-85.
Collett, D. (2015). Modelling survival data in medical research, Chapman and Hall/CRC.
Dalal, S., et al. (2011). "Non-communicable diseases in sub-Saharan Africa: what we know now." International journal of epidemiology 40(4): 885-901
Fissuh, Y. H. and G. Muletav (2015). "A joint model for a longitudinal pulse rate and respiratory rate of congestive heart failure patients: at Ayder Referral Hospital of Mekelle University, Tigray, Ethiopia." J Biom Biostat 6(5): 1.
Glezeva, N., et al. (2015). "Heart failure in sub‐Saharan Africa: review of the aetiology of heart failure and the role of point‐of‐care biomarker diagnostics." Tropical Medicine & International Health 20(5): 581-588.
Keates, A. K., et al. (2017). "Cardiovascular disease in Africa: epidemiological profile and challenges." Nature Reviews Cardiology 14(5): 273
Kraus, S., et al. (2016). "Heart failure in sub-Saharan Africa: A clinical approach." SAMJ: South African Medical Journal 106(1): 23-31.
Mensah, G., et al. (2015). "GBD 2013 Mortality and Causes of Death Collaborators. Mortality from cardiovascular diseases in sub-Saharan Africa, 1990–2013: a systematic analysis of data from the global burden of disease study 2013." Cardiovasc J Afr 26(2 Suppl 1): S6-10
Mozaffarian, D., et al. (2016). "Heart disease and stroke statistics-2016 update a report from the American Heart Association." Circulation 133(4): e38-e48.
Ntusi, N. B. and B. M. Mayosi (2009). "Epidemiology of heart failure in sub-Saharan Africa." Expert review of cardiovascular therapy 7(2): 169-180
Tefera, Y. G., et al. (2017). "The changing trend of cardiovascular disease and its clinical characteristics in Ethiopia: hospital-based observational study." Vascular health and risk management 13: 143